0001613377-19-000001.txt : 20190312 0001613377-19-000001.hdr.sgml : 20190312 20190312134035 ACCESSION NUMBER: 0001613377-19-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190227 FILED AS OF DATE: 20190312 DATE AS OF CHANGE: 20190312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PASCALE ADAM CENTRAL INDEX KEY: 0001613377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-27072 FILM NUMBER: 19674631 MAIL ADDRESS: STREET 1: 600 MAIN STREET STREET 2: SUITE 2 CITY: RIVERTON STATE: NJ ZIP: 08077 FORMER NAME: FORMER CONFORMED NAME: Pascale Adam DATE OF NAME CHANGE: 20140710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 BUSINESS PHONE: 215-988-0080 MAIL ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-02-27 0 0000946644 HEMISPHERX BIOPHARMA INC HEB 0001613377 PASCALE ADAM 600 MAIN STREET SUITE 2 RIVERTON NJ 08077 0 1 0 0 CFO Series B Convertible Preferred Stock 2019-02-27 4 X 0 10 A 10 D Warrants 2019-02-27 4 X 0 50000 A 50000 D Subr Rights(to buy) 1000 2019-02-27 4 X 0 10 1000 A 2019-02-14 2019-03-05 Pref Stk/Warrants 0 D Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Adam Pascale 2019-03-12